Clinical Trials Logo

Epiretinal Membrane clinical trials

View clinical trials related to Epiretinal Membrane.

Filter by:

NCT ID: NCT03583632 Completed - Epiretinal Membrane Clinical Trials

Visual Acuity and Optical Coherence Tomography One Year After Peeling of Epiretinal Membranes

Start date: February 1, 2018
Phase:
Study type: Observational

Improvement in visual acuity and retinal anatomy one year after surgery is assessed and compared to data preoperative and 3 months after surgery

NCT ID: NCT03457584 Completed - Epiretinal Membrane Clinical Trials

Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

Patients with intraretinal cystoid changes before scheduled membrane peeling for epiretinal membranes are included. Patients are randomized for balanced salt solution (BSS) or air-tamponade.

NCT ID: NCT03452748 Completed - Epiretinal Membrane Clinical Trials

Fourier Transformed Infrared Spectroscopy in Macular Surgery

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Epiretinal membranes (ERM) are disorders leading to vision loss and metamorphopsia. Vitrectomy with membrane peeling has developed to be the gold-standard in treatment of ERM. ERM can be well visualized with spectral domain optical coherence tomography (SD-OCT). The aim of the study is to examine ERM and internal limiting membranes (ILM) exzised during routine macular surgery with fourier transformed infrared spectroscopy (FTIR) and compare results to optic coherence tomography (OCT) findings.

NCT ID: NCT03404323 Completed - Cataract Clinical Trials

"Cataract Surgery in Eyes With Epiretinal Membrane"

Start date: July 1, 2015
Phase: N/A
Study type: Observational

The purpose of the study is to evaluate retinal thickness change and the occurrence of central structural retinal changes after uneventful small-incision cataract surgery in eyes with asymptomatic early stages of epiretinal membrane.

NCT ID: NCT03372759 Completed - Epiretinal Membrane Clinical Trials

Tilt of the Intraocular Lens in Patients Undergoing Combined Phacoemulsification and Vitrectomy With Airtamponade

Start date: December 2015
Phase: N/A
Study type: Interventional

Vitrectomy with membrane peeling has developed to be the gold-standard in treatment of epiretinal membranes. Due to the possibility of vitrectomy induced cataract, in many ophthalmic surgical centers it has become usual to indicate combined phacoemulsification and vitrectomy in case of existing cataract. Epiretinal membranes (ERM) and pseudomaculaforamen are disorders involving the posterior pole of the eyeball with consecutive vision loss. ERM can be well visualized with spectral domain optical coherence tomography (SD-OCT). Different study groups showed that even intraoperative use of SD-OCT is possible.

NCT ID: NCT03362580 Completed - Epiretinal Membrane Clinical Trials

Prevalence and Risk Factors of Epiretinal Membrane in Diabetic and Non-diabetic Patients

Start date: December 12, 2017
Phase:
Study type: Observational

Numerous terms have been used to describe epiretinal membrane (ERM): macular pucker, epimacular membrane, surface-wrinkling retinopathy, cellophane maculopathy and preretinal macular fibrosis. It is, by definition, a fibrocellular tissue found on the inner surface of the retina. It is semi-translucent and proliferates on or above the surface of the internal limiting membrane. It causes blurring and metamorphopsia, while mild cases are often asymptomatic. ERM presence can degrade the acuity and the quality of vision, thus affecting the quality of life. There is evidence that it also has an adverse impact to the treatment options for patients suffering from macular disorders. More specifically, regarding to diabetic retinopathy, ERM seems to have a bidirectional etiopathogenetic relationship with its course and complications. The aim of this study is to know the prevalence of ERM in the Brussel's population, the risk factors predisposing to ERM formation and if diabetic patients have a significantly higher prevalence of ERM in comparison to general population.

NCT ID: NCT03332758 Completed - Retinal Detachment Clinical Trials

Inflammasomes in Cell Death in FTMH, ERM, and RRD

Start date: September 8, 2017
Phase:
Study type: Observational

Prospective study evaluating the role of inflammasomes in cell death in retinal detachment, full thickness macular hole, and epiretinal membrane. The investigators are collecting vitreous and subretinal fluid samples from patients with these conditions and evaluating activity of the inflammasome pathway with established assays.

NCT ID: NCT03052881 Completed - Epiretinal Membrane Clinical Trials

Robotic Retinal Dissection Device Trial

R2D2
Start date: May 1, 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to determine whether use of a robotic system improves the precision and therefore safety of high precision steps in retinal surgery. Two common surgical scenarios (ERM/ILM peel and sub retinal haemorrhage displacement surgery) that require a high degree of precision to avoid damage to the retina have been chosen for this trial. These steps also have been selected because they allow a clearly definable outcome measure e.g. time taken to complete a specific step in the operation. The main issue here is that the patients will be undergoing this procedure regardless of enrolment in the trial - the only difference being that for study participants the surgeon will perform parts of the operation with the assistance of the robot.

NCT ID: NCT03045367 Completed - Epiretinal Membrane Clinical Trials

Mid-term Evaluation of Metamorphopsia in Epiretinal Membrane Surgery

Start date: June 22, 2015
Phase: N/A
Study type: Observational [Patient Registry]

This study evaluates the safety and efficacy simultaneous, trans-conjunctival, 25-Gauge vitrectomy and phacoemulsification with intraocular lens implant in patients with metamorphopsia and visual impairment due to idiopathic epiretinal membrane and cataract. All 30 patients recruited underwent complete ocular examination, visual acuity measurement with ETDRS, metamorphopsia assessment with M-Charts and Metamorphometry® and foveal thickness evaluation by sd-OCT preoperatively, at 30, 90, 180 days postoperatively.

NCT ID: NCT02836210 Completed - Epiretinal Membrane Clinical Trials

27-gauge Vitrectomy Wound Integrity: a Prospective, Randomized Trial Comparing Angled Versus Straight Entry

Start date: May 2015
Phase: N/A
Study type: Interventional

To prospectively compare clinical outcomes using straight (perpendicular) versus angled trocar insertion during 27 gauge pars plana vitrectomy surgery for epiretinal membrane Primary Endpoints: Sclerotomy suture rates and incidence of suture blebs at the end of 27 gauge MIVS. Secondary Endpoints: Rate of postoperative wound-related complications such as hypotony, choroidal detachments, endophthalmitis, and sclerotomy-related retinal tears with a minimum follow-up of 30 days.